Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Colorcon
Fish and Richardson
Accenture
Cipla
Johnson and Johnson
Deloitte
US Army
Boehringer Ingelheim
Mallinckrodt

Generated: April 21, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 021503

« Back to Dashboard

NDA 021503 describes VIRACEPT, which is a drug marketed by Agouron Pharms and is included in three NDAs. It is available from four suppliers. Additional details are available on the VIRACEPT profile page.

The generic ingredient in VIRACEPT is nelfinavir mesylate. There are three drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the nelfinavir mesylate profile page.
Summary for 021503
Tradename:VIRACEPT
Applicant:Agouron Pharms
Ingredient:nelfinavir mesylate
Patents:0
Therapeutic Class:Antivirals
Formulation / Manufacturing:see details
Pharmacology for NDA: 021503
Medical Subject Heading (MeSH) Categories for 021503
Suppliers and Packaging for NDA: 021503
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
VIRACEPT nelfinavir mesylate TABLET;ORAL 021503 NDA State of Florida DOH Central Pharmacy 53808-0809 N 53808-0809-1
VIRACEPT nelfinavir mesylate TABLET;ORAL 021503 NDA AGOURON 63010-027 N 63010-027-70

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrengthEQ 625MG BASE
Approval Date:Apr 30, 2003TE:RLD:Yes

Expired US Patents for NDA 021503

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Agouron Pharms VIRACEPT nelfinavir mesylate TABLET;ORAL 021503-001 Apr 30, 2003 ➤ Try a Free Trial ➤ Try a Free Trial
Agouron Pharms VIRACEPT nelfinavir mesylate TABLET;ORAL 021503-001 Apr 30, 2003 ➤ Try a Free Trial ➤ Try a Free Trial
Agouron Pharms VIRACEPT nelfinavir mesylate TABLET;ORAL 021503-001 Apr 30, 2003 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Boehringer Ingelheim
Harvard Business School
Johnson and Johnson
Cerilliant
Queensland Health
AstraZeneca
Covington
Colorcon
QuintilesIMS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.